{
  "schema_version": "0.4",
  "ir_kind": "hl",
  "metadata": {
    "title": "Apply morphogen treatments with varying timing, concentration, and combination",
    "source": {
      "type": "paper",
      "id": "s41592-025-02927-5.pdf"
    }
  },
  "resources": {
    "materials": [],
    "containers": [],
    "equipment": [],
    "samples": [],
    "data": []
  },
  "protocol": {
    "steps": [
      {
        "id": "s1",
        "op": "annotate",
        "inputs": [],
        "outputs": [],
        "params": {},
        "annotations": {
          "description": "Developing organoids were then subjected to a panel of morphogen treatments with varying timing, concentration and combination of the molecules CHIR99021 (CHIR, WNT pathway activator), XAV939 (WNT pathway inhibitor), rh-SHH/CS24II (SHH) and purmorphamine, FGF-8B (FGF8), RA, rhBMP-4 (BMP4), rhBMP-7 (BMP7)"
        }
      }
    ],
    "start_step_id": "s1",
    "edges": [
      {
        "from": "s1",
        "to": "s1"
      }
    ],
    "detail_level": 0
  }
}